» Articles » PMID: 19513802

Prevalence of Chronic Kidney Disease in the Japanese General Population

Abstract

Background: We previously estimated the prevalence of chronic kidney disease (CKD) stages 3-5 at 19.1 million based on data from the Japanese annual health check program for 2000-2004 using the Modification of Diet in Renal Disease (MDRD) equation multiplied by the coefficient 0.881 for the Japanese population. However, this equation underestimates the GFR, particularly for glomerular filtration rates (GFRs) of over 60 ml/min/1.73 m(2). We did not classify the participants as CKD stages 1 and 2 because we did not obtain proteinuria data for all of the participants. We re-estimated the prevalence of CKD by measuring proteinuria using a dipstick test and by calculating the GFR using a new equation that estimates GFR based on data from the Japanese annual health check program in 2005.

Methods: Data were obtained for 574,024 (male 240,594, female 333,430) participants over 20 years old taken from the general adult population, who were from 11 different prefectures in Japan (Hokkaido, Yamagata, Fukushima, Tochigi, Ibaraki, Tokyo, Kanazawa, Osaka, Fukuoka, Miyazaki and Okinawa) and took part in the annual health check program in 2005. The glomerular filtration rate (GFR) of each participant was computed from the serum creatinine value using a new equation: GFR (ml/min/1.73 m(2)) = 194 x Age(-0.287) x S-Cr(-1.094) (if female x 0.739). The CKD population nationwide was calculated using census data from 2005. We also recalculated the prevalence of CKD in Japan assuming that the age composition of the population was same as that in the USA.

Results: The prevalence of CKD stages 1, 2, 3, and 4 + 5 were 0.6, 1.7, 10.4 and 0.2% in the study population, which resulted in predictions of 0.6, 1.7, 10.7 and 0.2 million patients, respectively, nationwide. The prevalence of low GFR was significantly higher in the hypertensive and proteinuric populations than it was in the populations without proteinuria or hypertension. The prevalence rate of CKD in Japan was similar to that in the USA when the Japanese general population was age adjusted to the US 2005 population estimate.

Conclusion: About 13% of the Japanese adult population-approximately 13.3 million people-were predicted to have CKD in 2005.

Citing Articles

Comparative assessment of the effects of dotinurad and febuxostat on the renal function in chronic kidney disease patients with hyperuricemia.

Takata T, Taniguchi S, Mae Y, Kageyama K, Fujino Y, Iyama T Sci Rep. 2025; 15(1):8990.

PMID: 40089552 DOI: 10.1038/s41598-025-94020-2.


Exploring factors associated with Kidney Disease Quality of Life in patients with advanced chronic kidney disease: the Reach-J CKD cohort study.

Nakamura H, Okubo R, Kumagai M, Anayama M, Makino Y, Tamura K Clin Exp Nephrol. 2025; .

PMID: 39870981 DOI: 10.1007/s10157-025-02628-5.


Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34 cell therapy: A clinical trial.

Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H World J Stem Cells. 2024; 16(12):1012-1021.

PMID: 39734483 PMC: 11669983. DOI: 10.4252/wjsc.v16.i12.1012.


Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective.

Igarashi A, Ohara K, Matsuda H, Morii J, Jagannathan S, Filomeno R Adv Ther. 2024; 42(2):995-1008.

PMID: 39688813 PMC: 11787189. DOI: 10.1007/s12325-024-03084-5.


Aspartate/alanine aminotransferase ratio and development of chronic kidney disease in non-diabetic men and women: a population-based longitudinal study in Kagawa, Japan.

Okawa Y, Mitsuhashi T, Suzuki E Clin Exp Nephrol. 2024; .

PMID: 39641865 DOI: 10.1007/s10157-024-02601-8.


References
1.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

2.
Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y . Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008; 51(3):373-84. DOI: 10.1053/j.ajkd.2007.11.009. View

3.
Hallan S, Coresh J, Astor B, Asberg A, Powe N, Romundstad S . International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006; 17(8):2275-84. DOI: 10.1681/ASN.2005121273. View

4.
Amin R, Turner C, Van Aken S, Bahu T, Watts A, Lindsell D . The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int. 2005; 68(4):1740-9. DOI: 10.1111/j.1523-1755.2005.00590.x. View

5.
Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S . Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007; 11(1):41-50. DOI: 10.1007/s10157-006-0453-4. View